Literature DB >> 23174033

Pharmacological insights into the role of P2X4 receptors in behavioural regulation: lessons from ivermectin.

Marco Bortolato1, Megan M Yardley, Sheraz Khoja, Sean C Godar, Liana Asatryan, Deborah A Finn, Ronald L Alkana, Stan G Louie, Daryl L Davies.   

Abstract

Purinergic ionotropic P2X receptors are a family of cation-permeable channels that bind extracellular adenosine 5'-triphosphate. In particular, convergent lines of evidence have recently highlighted P2X(4) receptors as a potentially critical target in the regulation of multiple nervous and behavioural functions, including pain, neuroendocrine regulation and hippocampal plasticity. Nevertheless, the role of the P2X(4) receptor in behavioural organization remains poorly investigated. To study the effects of P2X(4) activation, we tested the acute effects of its potent positive allosteric modulator ivermectin (IVM, 2.5-10 mg/kg i.p.) on a broad set of paradigms capturing complementary aspects of perceptual, emotional and cognitive regulation in mice. In a novel open field, IVM did not induce significant changes in locomotor activity, but increased the time spent in the peripheral zone. In contrast, IVM produced anxiolytic-like effects in the elevated plus maze and marble burying tasks, as well as depression-like behaviours in the tail-suspension and forced swim tests. The agent induced no significant behavioural changes in the conditioned place preference test and in the novel object recognition task. Finally, the drug induced a dose-dependent decrease in sensorimotor gating, as assessed by pre-pulse inhibition (PPI) of the acoustic startle reflex. In P2X(4) knockout mice, the effects of IVM in the open field and elevated plus maze were similar to those observed in wild type mice; conversely, the drug significantly increased startle amplitude and failed to reduce PPI. Taken together, these results suggest that P2X(4) receptors may play a role in the regulation of sensorimotor gating.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23174033      PMCID: PMC3593990          DOI: 10.1017/S1461145712000909

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  62 in total

1.  Distinct Localization of P2X receptors at excitatory postsynaptic specializations.

Authors:  M E Rubio; F Soto
Journal:  J Neurosci       Date:  2001-01-15       Impact factor: 6.167

2.  Biochemical and functional evidence for heteromeric assembly of P2X1 and P2X4 subunits.

Authors:  Annette Nicke; Daniel Kerschensteiner; Florentina Soto
Journal:  J Neurochem       Date:  2005-02       Impact factor: 5.372

3.  Locomotory patterns, spatiotemporal organization of exploration and spatial memory in serotonin transporter knockout mice.

Authors:  Allan V Kalueff; Catherine L Jensen; Dennis L Murphy
Journal:  Brain Res       Date:  2007-07-14       Impact factor: 3.252

4.  Characterization of purinergic P2X4 receptor channels expressed in anterior pituitary cells.

Authors:  Hana Zemkova; Marek Kucka; Shuo Li; Arturo E Gonzalez-Iglesias; Melanija Tomic; Stanko S Stojilkovic
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-12-15       Impact factor: 4.310

5.  Relations between open-field, elevated plus-maze, and emergence tests in C57BL/6J and BALB/c mice injected with GABA- and 5HT-anxiolytic agents.

Authors:  Robert Lalonde; Catherine Strazielle
Journal:  Fundam Clin Pharmacol       Date:  2009-09-03       Impact factor: 2.748

6.  Clinical signs and biochemical changes in calves caused by injection of ivermectin.

Authors:  C D Basudde
Journal:  Vet Q       Date:  1989-01       Impact factor: 3.320

Review 7.  P2X receptors as cell-surface ATP sensors in health and disease.

Authors:  Baljit S Khakh; R Alan North
Journal:  Nature       Date:  2006-08-03       Impact factor: 49.962

8.  Methamphetamine neurotoxicity increases brain expression and alters behavioral functions of CB₁ cannabinoid receptors.

Authors:  Marco Bortolato; Roberto Frau; Valentina Bini; William Luesu; Roberta Loriga; Maria Collu; Gian Luigi Gessa; M Grazia Ennas; M Paola Castelli
Journal:  J Psychiatr Res       Date:  2010-04-07       Impact factor: 4.791

9.  Novel monoamine oxidase A knock out mice with human-like spontaneous mutation.

Authors:  Anna L Scott; Marco Bortolato; Kevin Chen; Jean C Shih
Journal:  Neuroreport       Date:  2008-05-07       Impact factor: 1.837

10.  Comparative pharmacology and computational modelling yield insights into allosteric modulation of human alpha7 nicotinic acetylcholine receptors.

Authors:  David B Sattelle; Steven D Buckingham; Miki Akamatsu; Kazuhiko Matsuda; Ilse S Pienaar; Ilse Pienaar; Andrew K Jones; Benedict M Sattelle; Andrew Almond; Charles D Blundell
Journal:  Biochem Pharmacol       Date:  2009-06-21       Impact factor: 5.858

View more
  23 in total

1.  Gene-environment interactions in antisocial behavior are mediated by early-life 5-HT2A receptor activation.

Authors:  Sean C Godar; Laura J Mosher; Simona Scheggi; Paola Devoto; Kelly M Moench; Hunter J Strathman; Cori M Jones; Roberto Frau; Miriam Melis; Carla Gambarana; Brent Wilkinson; M Graziella DeMontis; Stephen C Fowler; Marcelo P Coba; Cara L Wellman; Jean C Shih; Marco Bortolato
Journal:  Neuropharmacology       Date:  2019-02-01       Impact factor: 5.250

2.  Avermectins differentially affect ethanol intake and receptor function: implications for developing new therapeutics for alcohol use disorders.

Authors:  Liana Asatryan; Megan M Yardley; Sheraz Khoja; James R Trudell; Nhat Hyunh; Stan G Louie; Nicos A Petasis; Ronald L Alkana; Daryl L Davies
Journal:  Int J Neuropsychopharmacol       Date:  2014-01-22       Impact factor: 5.176

3.  Contribution of P2X4 receptors to ethanol intake in male C57BL/6 mice.

Authors:  Letisha R Wyatt; Deborah A Finn; Sheraz Khoja; Megan M Yardley; Liana Asatryan; Ronald L Alkana; Daryl L Davies
Journal:  Neurochem Res       Date:  2014-03-27       Impact factor: 3.996

4.  A Pilot Study of the Safety and Initial Efficacy of Ivermectin for the Treatment of Alcohol Use Disorder.

Authors:  Daniel J O Roche; Megan M Yardley; Katy F Lunny; Stan G Louie; Daryl L Davies; Karen Miotto; Lara A Ray
Journal:  Alcohol Clin Exp Res       Date:  2016-04-18       Impact factor: 3.455

5.  Role of purinergic P2X4 receptors in regulating striatal dopamine homeostasis and dependent behaviors.

Authors:  Sheraz Khoja; Vivek Shah; Damaris Garcia; Liana Asatryan; Michael W Jakowec; Daryl L Davies
Journal:  J Neurochem       Date:  2016-08-15       Impact factor: 5.372

6.  Preclinical development of moxidectin as a novel therapeutic for alcohol use disorder.

Authors:  Nhat Huynh; Natalie Arabian; Anna Naito; Stan Louie; Michael W Jakowec; Liana Asatryan; Daryl L Davies
Journal:  Neuropharmacology       Date:  2016-09-15       Impact factor: 5.250

Review 7.  Implication of Neuronal Versus Microglial P2X4 Receptors in Central Nervous System Disorders.

Authors:  Alexia Duveau; Eléonore Bertin; Eric Boué-Grabot
Journal:  Neurosci Bull       Date:  2020-09-05       Impact factor: 5.203

Review 8.  Ivermectin and its target molecules: shared and unique modulation mechanisms of ion channels and receptors by ivermectin.

Authors:  I-Shan Chen; Yoshihiro Kubo
Journal:  J Physiol       Date:  2017-11-09       Impact factor: 5.182

Review 9.  Preclinical evaluation of avermectins as novel therapeutic agents for alcohol use disorders.

Authors:  Sheraz Khoja; Nhat Huynh; Alicia M P Warnecke; Liana Asatryan; Michael W Jakowec; Daryl L Davies
Journal:  Psychopharmacology (Berl)       Date:  2018-03-02       Impact factor: 4.530

10.  Steroid 5α-reductase 2 deficiency leads to reduced dominance-related and impulse-control behaviors.

Authors:  Laura J Mosher; Sean C Godar; Marc Morissette; Kenneth M McFarlin; Simona Scheggi; Carla Gambarana; Stephen C Fowler; Thérèse Di Paolo; Marco Bortolato
Journal:  Psychoneuroendocrinology       Date:  2018-02-16       Impact factor: 4.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.